Why Layered Packaging Matters for Stability

Multi-layer packaging structures are widely used in pharmaceutical blister packs, sachets, and pouches to provide functional barriers against environmental stressors. These include:

• ✓ Moisture ingress
• ✓ Oxygen permeation
• ✓ Light exposure
• ✓ Mechanical damage
• ✓ Chemical interactions with packaging

Stability studies that ignore the effect of packaging layers may underestimate or overstate product shelf life.

Typical Packaging Layer Structures in Pharma

Below are common multilayer combinations used in pharmaceutical packaging:

• Blister Packs: PVC/Alu, PVC/PVDC/Alu, Aclar/Alu, Alu/Alu
• Sachets: PET/Alu/PE or OPA/Alu/PE
• Bottles: HDPE with inner or outer barrier coating, multilayer PP with EVOH

Each layer contributes a specific functionality, such as structural support, printability, sealability, or barrier protection.

Functional Roles of Packaging Layers

Selection of layers should align with the product’s physicochemical properties and ICH stability zone requirements.

Impact of Layers on Stability Parameters

Packaging layers influence the following stability-critical factors:

• Moisture Uptake: Thin PVC alone allows water vapor ingress. Adding PVDC or Aclar significantly reduces WVTR.
• Oxygen Sensitivity: Products prone to oxidation benefit from Alu/Alu or EVOH layers that offer near-zero oxygen permeability.
• Photostability: Amber laminates or aluminum foil reduce exposure to UV and visible light.
• Mechanical Protection: Thicker laminates or PET provide rigidity and prevent rupture or tearing.

Testing the Effectiveness of Packaging Layers

During stability studies, the following evaluations confirm packaging layer suitability:

• ☑ Moisture Vapor Transmission Rate (MVTR): Assessed as per USP or ASTM standards
• ☑ Oxygen Transmission Rate (OTR): Evaluated using specialized gas permeability analyzers
• ☑ Light Transmission: Measured with spectrophotometers, particularly in the 290–450 nm range
• ☑ Seal Integrity: Vacuum or pressure decay methods help validate the effectiveness of the heat seal layer

These properties must be maintained throughout the product’s intended shelf life under the specified ICH conditions.

Case Study: Blister Layer Upgrade During Development

A pharmaceutical company initially used PVC/Alu blisters for a hygroscopic tablet. During the 6-month accelerated stability test, the tablets showed increased weight and decreased assay values. Root cause analysis pointed to poor moisture barrier. The company upgraded to PVC/PVDC/Alu blisters, which successfully retained product quality under the same conditions. This example illustrates how layer selection affects real-world product performance.

Checklist for Evaluating Packaging Layers in Stability Protocols

• ☑ Are the individual layers and their materials clearly described?
• ☑ Is each layer’s function aligned with product sensitivity?
• ☑ Have barrier properties (WVTR, OTR) been measured?
• ☑ Is compatibility with product components confirmed?
• ☑ Are the specifications traceable to SOPs or external standards?
• ☑ Are results documented in CTD Module 3.2.P.7?

Regulatory Expectations for Multi-Layer Packaging

According to regulatory agencies like EMA and Regulatory compliance guidelines:

• Each material layer must be described and justified in the dossier
• Barrier properties must support stability claims (esp. for Zone IV countries)
• Packaging configuration must match what is used in the marketed product
• Data must include validation and performance test outcomes

Conclusion

The effect of packaging layers on pharmaceutical stability is profound. By understanding and evaluating the functional roles of each layer—whether it’s to block moisture, oxygen, or light—you ensure product integrity and regulatory compliance. Including quantitative barrier data and case-based justification in your stability protocol strengthens your submission and protects patients.

References:

• ICH Q1A(R2): Stability Testing of New Drug Substances and Products
• USP : Containers – Performance Testing
• ASTM F1249: Water Vapor Transmission Rate Testing
• FDA Guidance: Container Closure Systems
• WHO Stability Testing Guidelines, Annex 10